Stockreport

Adagene to Present at the Leerink Partners Global Biopharma Conference 2024

Adagene Inc. - ADS, each representing 1.25 ordinary shares  (ADAG) 
PDF SAN DIEGO and SUZHOU, China, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel a [Read more]